No added sugar: CCDC134 stabilizes ER chaperone Gp96 for TLR biogenesis
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20242285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Antje Blumenthal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland , Brisbane, Australia. Hauptthemen laut MEDLINE: Molecular Chaperones, Endoplasmic Reticulum, Membrane Glycoproteins, Toll-Like Receptors. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Australian Research Council Future Fellowship, National Health and Medical Research Council of Australia.
Abstract (Originalsprache)
Bernaleau et al. (https://doi.org/10.1084/jem.20240825) show that CCDC134 located in the ER is required for TLR biogenesis by controlling the N-glycosylation, folding, and stabilization of the ER chaperone Gp96.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Frazer Institute, The University of Queensland , Brisbane, Australia.
ORCID-Profile: Antje Blumenthal, Leslie C Domínguez Cadena
Förderung
- Australian Research Council Future Fellowship
- National Health and Medical Research Council of Australia
Zitieren
APA
Blumenthal, A., & Domínguez Cadena, L. C. (2025). No added sugar: CCDC134 stabilizes ER chaperone Gp96 for TLR biogenesis. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20242285
Vancouver
Blumenthal A, Domínguez Cadena LC. No added sugar: CCDC134 stabilizes ER chaperone Gp96 for TLR biogenesis. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20242285
BibTeX
@article{Blumenthal2025,
author = {Blumenthal, Antje and Domínguez Cadena, Leslie C},
title = {No added sugar: CCDC134 stabilizes ER chaperone Gp96 for TLR biogenesis},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20242285}
}
EUVIMED